Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort
Arthritis Research & Therapy volume 23, Article number: 263 (2021)
Correction to: Arthritis Res Ther 23, 210 (2021)
Following publication of the original article , the authors have requested to update the Acknowledgement section and added the following statements:
We would like to thank the PREVeNT-RA participants and principal investigators as follows: Dr Michael Batley - Maidstone and Tunbridge Wells NHS Trust, Dr Marwan Bukhari - Royal Lancaster Infirmary, Lancaster, Dr James Burns - Antrim Area Hospital, Northern Ireland, Dr Lucy Coates - Tameside General Hospital, Manchester, Dr Andrew Cope - Guy’s Hospital, London, Dr Emily Deeney - Queen Elizabeth Hospital, Gateshead, Dr Karen Douglas - Russells Hall Hospital, Dudley, Dr Paul Emery - Leeds Teaching Hospital, Dr Andrew Filer - Birmingham Queen Elizabeth hospital, Dr Charlotte Filer - Stepping Hill Hospital, Stockport, Dr James Galloway - Kings College hospital, London, Dr Phillip Gardiner - Altnagelvin Hospital (Western Health and Social Care Trust), Northern Ireland, Dr John Isaacs - Freeman Hospital, Newcastle, Dr Rachel Jeffrey - Northampton General Hospital, Dr Sophia Khan - Heart of England NHS foundation Trust, Solihull, Dr Suzanne Lane - Ipswich Hospital, Suffolk, Dr Sara Littlejohns - North Devon District Hospital, Barnstable, Dr Kirsten Mackay - Torbay Hospital, Torquay, Dr Nicola Maiden - Craigavon Area Hospital, Portadown, Dr Tarnya Marshall - Norfolk and Norwich University Hospital, Norfolk, Dr Sophia Naz - Fairfield General Hospital, Bury, Dr Sophia Naz - North Manchester General Hospital, Manchester, Dr Terence O'Neill - Salford Royal Hospital, Salford, Dr Ira Pande - Queens Medical Centre, Nottingham, Dr Yusef Patel - Hull Royal Infirmary, Hull, Dr Anandita Paul - Bolton NHS Foundation Trust, Dr John Pauling - Royal National Mineral Hospital for Rheumatic Diseases, Bath, Dr Adrian Peall - The County Hospital, Hereford, Dr Suzannah Pegler - Great Western Hospital, Swindon, Dr Helen Prady - Warrington and Halton Teaching Hospitals NHS Foundation Trust, Warrington, Dr Karim Raza - Birmingham City Hospital, Birmingham, Dr Lindsay Robertson - Derriford Hospital, Plymouth, Dr Richard Smith - Salisbury District Hospital, Wiltshire, Dr Peter Taylor - Oxford University Hospitals NHS Foundation Trust, Oxford, Dr Julia Taylor - Poole Hospital, Dorset, Jessica Thrush - Worcestershire Acute Hospitals NHS Trust, Redditch Dr Lisa Trembath - Royal Cornwall Hospital, Truro, Professor David Walsh - Sherwood Forest Hospitals NHS Foundation Trust, Nottinghamshire, Dr Pippa Watson - Manchester University NHS Foundation Trust, Manchester, Professor Simon Bowman - Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, Helena Cox - Burton Hospitals (Queens Hospital) & Royal Derby Hospital, Dr Emily Deeney - Gateshead Health NHS Foundation Trust, Gateshead, Dr Sam Hider - Haywood Hospital, Stoke, Dr Cath Lawson - Harrogate District Hospital, Harrogate, Dr Paul McCabe - Trafford General Hospital, Manchester, Dr Constantino Pitzalis - Mile End Hospital, London, Dr Lee Suan - The Royal Blackburn Hospital, Blackburn, Dr Louise Warburton - Shropshire Community Health NHS Trust, Shrewsbury.
The original article  has been updated.
Costello RE, Humphreys JH, Sergeant JC, et al. Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort. Arthritis Res Ther. 2021;23:210. https://doi.org/10.1186/s13075-021-02593-w.
About this article
Cite this article
Costello, R.E., Humphreys, J.H., Sergeant, J.C. et al. Correction to: Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the Preclinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort. Arthritis Res Ther 23, 263 (2021). https://doi.org/10.1186/s13075-021-02645-1